BioTech/Drugs - Montreal, Québec, N/A
C3i, a Centre of Excellence for Commercialisation and Research, will accelerate access to innovative therapies in immuno-oncology and regenerative medicine for patients. Operating in Montreal, Canada, C3i offers an integrated structure for the development, translation and commercialisation of these ground breaking therapies.Acting as a "one-stop-shop" solution for the development, translation, and commercialisation of cancer immunotherapy, C3i combines four interacting units: - GMP Manufacturing Unit for Regenerative Medicine and Cancer Immunotherapy - Biomarker-Diagnostic Unit - Clinical Research Unit and a CRO - Innovation and Commercialisation Unit
Outlook
Apache
Google Font API
Mobile Friendly
YouTube